Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell of proximal tubule | 9 studies | 40% ± 12% | |
hepatocyte | 5 studies | 71% ± 16% | |
glutamatergic neuron | 3 studies | 27% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 12612.60 | 226 / 226 | 90% | 146.98 | 367 / 406 |
kidney | 100% | 5357.28 | 89 / 89 | 77% | 36.55 | 698 / 901 |
adrenal gland | 100% | 537.91 | 258 / 258 | 47% | 2.80 | 107 / 230 |
prostate | 87% | 263.95 | 214 / 245 | 31% | 3.01 | 158 / 502 |
lung | 85% | 76.60 | 492 / 578 | 1% | 0.21 | 17 / 1155 |
brain | 68% | 46.61 | 1788 / 2642 | 1% | 0.04 | 5 / 705 |
adipose | 64% | 497.70 | 773 / 1204 | 0% | 0 | 0 / 0 |
breast | 52% | 53.59 | 239 / 459 | 0% | 0.02 | 3 / 1118 |
ovary | 44% | 18.17 | 79 / 180 | 2% | 0.10 | 8 / 430 |
uterus | 37% | 15.66 | 63 / 170 | 1% | 0.17 | 5 / 459 |
spleen | 35% | 23.89 | 84 / 241 | 0% | 0 | 0 / 0 |
skin | 17% | 6.23 | 299 / 1809 | 3% | 0.16 | 13 / 472 |
pancreas | 13% | 3.26 | 41 / 328 | 1% | 0.08 | 2 / 178 |
intestine | 10% | 5.20 | 100 / 966 | 0% | 0.19 | 2 / 527 |
peripheral blood | 10% | 8.24 | 96 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 10% | 3.57 | 133 / 1335 | 0% | 0 | 0 / 0 |
stomach | 8% | 2.76 | 29 / 359 | 1% | 0.03 | 2 / 286 |
esophagus | 8% | 2.38 | 113 / 1445 | 0% | 0 | 0 / 183 |
thymus | 2% | 0.71 | 16 / 653 | 4% | 2.30 | 26 / 605 |
bladder | 5% | 1.00 | 1 / 21 | 0% | 0.02 | 1 / 504 |
muscle | 3% | 0.85 | 23 / 803 | 0% | 0 | 0 / 0 |
heart | 3% | 1.30 | 23 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046050 | Biological process | UMP catabolic process |
GO_0046079 | Biological process | dUMP catabolic process |
GO_0006212 | Biological process | uracil catabolic process |
GO_0006210 | Biological process | thymine catabolic process |
GO_0006248 | Biological process | CMP catabolic process |
GO_0006208 | Biological process | pyrimidine nucleobase catabolic process |
GO_0006249 | Biological process | dCMP catabolic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0004157 | Molecular function | dihydropyrimidinase activity |
GO_0051219 | Molecular function | phosphoprotein binding |
GO_0005515 | Molecular function | protein binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | DPYS |
Protein name | Dihydropyrimidinase (DHP) (DHPase) (EC 3.5.2.2) (Dihydropyrimidine amidohydrolase) (Hydantoinase) Dihydropyrimidinase |
Synonyms | |
Description | FUNCTION: Catalyzes the second step of the reductive pyrimidine degradation, the reversible hydrolytic ring opening of dihydropyrimidines. Can catalyze the ring opening of 5,6-dihydrouracil to N-carbamyl-alanine and of 5,6-dihydrothymine to N-carbamyl-amino isobutyrate. |
Accessions | Q14117 E5RG28 H0YEV7 ENST00000533874.1 ENST00000351513.7 ENST00000521573.2 |